Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
President Barack Obama recently pledged to restore the United States to a position of global leadership in research and technology, but Nature examines how sequestration threatens research funding.
GHTC members the Drugs for Neglected Diseases initiative (DNDi) and the Medicines for Malaria Venture (MMV) announced the identification of three chemical series that could lead to new treatments for neglected tropical diseases. The series were made possible by MMV's open access Malaria Box.
The US Agency for International Development recently announced the launch of its Higher Education Solutions Network—a new partnership with seven top American and foreign universities designed to develop innovative solutions to global development challenges, including global health.
Pharmaceutical companies Johnson & Johnson, Merck, and Eli Lilly plan to launch a one-stop database of global clinical trial sites aimed at streamlining paperwork and speeding the process for testing new drugs.
A US Food and Drug Administration panel voted unanimously to recommend the effectiveness of a new hepatitis B vaccine but also raised concerns about its safety, asking for more data from studies on a wider population.